Physician profile
John D Amsbury
NPI 1336304906
$780.28
in general payments reported to CMS, 2019-2025
12 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $46.45 · 2021: $58.16 · 2022: $80.35 · 2023: $27.40 · 2024: $310 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $245 · Food and Beverage: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $244.57 |
| Food and Beverage | $238.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $299.91 | 2021-2024 | |
| Abbvie INC. | $117.89 | 2019-2021 | |
| Ethicon US, LLC | $102.55 | 2025 | Stratafix, Ethicon |
| Myovant Sciences INC. | $80.35 | 2022 | |
| Organon LLC | $43.22 | 2025 | Jada System |
| Astellas Pharma US INC | $33.35 | 2019 | |
| Becton, Dickinson and Company | $29.66 | 2019 | |
| Daiichi Sankyo INC. | $17.00 | 2024 | Injectafer |
| Sage Therapeutics, LLC | $15.77 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.15 | 2023 | |
| Sumitomo Pharma America, INC. | $13.25 | 2023 | Myfembree |
| Channel Medsystems, INC. | $13.18 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Amsbury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.